Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy.

@article{Kang2015UltrasensitivePS,
  title={Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy.},
  author={Jung Julie Kang and Robert Evan Reiter and Michael L. Steinberg and Christopher Ryan King},
  journal={The Journal of urology},
  year={2015},
  volume={193 5},
  pages={1532-8}
}
PURPOSE Integrating ultrasensitive prostate specific antigen with surveillance in patients at high risk after radical prostatectomy potentially optimizes treatment by correctly identifying recurrence, promoting an early salvage strategy and minimizing overtreatment. We tested the power of postoperative ultrasensitive prostate specific antigen to identify eventual biochemical failure. MATERIALS AND METHODS We identified 247 patients at high risk with a median followup of 44 months who… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 9 times over the past 90 days. VIEW TWEETS